Clinical Trial Update: Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic Patients [NA]

View source ↗

Summary

A completed clinical trial evaluating safety, acceptability, and efficacy of a diabetes-specific low-carbohydrate, high-monounsaturated-fatty-acid oral nutritio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Diabetes-specific oral nutritional supplement (low-carbohydrate, high-monounsaturated fatty acids)

Snippet

Sponsor: Fresenius Kabi | Conditions: Diabetes | NA | Status: COMPLETED